HGHFX Mutual Fund

NAV$45.41

Fund Essentials - as of Jan 31, 2026

Net Assets
$24M
Expense Ratio
0.92%
Dividend Yield (Current)
3.08%
Holdings
84
Inception Date
Feb 28, 2017
Fund Family
Hartford Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+5.24%
1 Year+33.03%
3 Year+8.82%
5 Year+5.55%

Asset Allocation

Stocks: 99.68%
Bonds: 0.19%
Cash: 0.14%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co13.12%
MRKMerck & Company Inc5.74%
JNJJohnson & Johnson5.07%
UNHUnitedhealth Group Incorporated4.64%
ABBVAbbvie Inc.3.84%
Top 10 Concentration: 47.48%Report Date: Jan 31, 2026
Download all 84 holdings for HGHFX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.08%
Frequency
Annually
Latest Distribution
$4.37
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how HGHFX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

HGHFX Mutual Fund Overview

HGHFX Mutual Fund (The Hartford Healthcare Fund Class F) is managed by Hartford Funds with $24.2M in net assets. HGHFX expense ratio is 0.92%, holding 84 positions across sectors including Health Care, Unknown, Financials. Inception date: 2017-02-28.

HGHFX performance shows a YTD return of 5.24%. The 1-year return is 33.03% and the 5-year return is 5.55%. HGHFX dividend yield stands at 3.08%, paid annually.

HGHFX top holdings include Eli Lilly & Co (13.1%), Merck & Company Inc (5.7%), Johnson & Johnson (5.1%), Unitedhealth Group Incorporated (4.6%), Abbvie Inc. (3.8%). View all HGHFX holdings, sector breakdown, or dividend history.

HGHFX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HGHFX alternatives are available via the screener, along with tax-loss harvesting opportunities.